DiaMedica Therapeutics Inc. (DMAC) EPS (Basic) (2018 - 2019)
DiaMedica Therapeutics (DMAC) has 2 years of EPS (Basic) data on record, last reported at -$0.21 in Q4 2019.
- For Q4 2019, EPS (Basic) rose 8.7% year-over-year to -$0.21; the TTM value through Dec 2019 reached -$0.89, down 20.27%, while the annual FY2024 figure was -$0.6, 0.0% changed from the prior year.
- EPS (Basic) reached -$0.21 in Q4 2019 per DMAC's latest filing, down from -$0.2 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.1 in Q1 2018 and bottomed at -$0.27 in Q1 2019.